Hipra mycoplasma vaccine


Hipra's mypravac suis vaccine is for the prevention of respiratory disease due to Mycoplasma hyopneumoniae. It protects from the first week of life to the end of grow-finishing. The vaccine presents a new combination of adjuvants based on levamisole and carbomer, offering higher and longer-lasting immunity while avoiding adverse reactions since it is non-oil based. Administration is also improved.

Fill out the form below to request more information about Hipra mycoplasma vaccine